Skip to main content

At Padagis, we are dedicated to expanding access to high-quality, affordable medications that support better health outcomes. With a focus on topical and other non-oral pharmaceutical products, we manufacture a broad range of prescription and over-the-counter treatments. Our team is committed to innovation, reliability, and reducing healthcare costs—helping patients and healthcare providers get the care they need with confidence.

Products

At Padagis, we offer a broad portfolio of extended topical products—including prescription creams, ointments, gels, foams, sprays, patches, nasal treatments, and suppositories. We specialize in Paragraph IV products, developing and manufacturing treatments that focus on the complexities of branded pharmaceutical patents. Our goal is simple: to make high-quality, trusted medications more accessible and affordable for the people who need them.

See Our Full Product Line

Business Development

Strong partnerships are a big part of what makes Padagis a leader in generic extended topicals. We collaborate with companies through licensing agreements, joint ventures, marketing partnerships, and distribution deals. Our efforts are especially focused in three key areas:

  • Research and Development
  • Strategic Alliance and Product Acquisitions
  • Contract Manufacturing
Explore What We Can Build Together
Padagis Announces Two First-to-file Anda Submissions

Padagis Announces Two First-to-file Anda Submissions

June 17, 2025
Padagis announces the acquisition of 17,000 square meter facility in Yerucham, Israel

Padagis announces the acquisition of 17,000 square meter facility in Yerucham, Israel

June 17, 2025
Padagis Announces The First Launch Of An Over-the-counter Naloxone Nasal Spray In The United States

Padagis Announces The First Launch Of An Over-the-counter Naloxone Nasal Spray In The United States

June 17, 2025

Want to Connect?

Connect